Clinical value of echocardiography in patients with COVID-19: a systematic review
https://doi.org/10.33667/2078-5631-2020-32-8-13
Abstract
This systematic review is dedicated to the role of echocardiography in diagnostics of possible cardiovascular complications in patients with COVID-19, the emerging infectious disease that has recently challenged global healthcare. The results of the largest current available clinical studies on the given topic from the leading medical databases were analyzed. Up-to-date data about the beneficial advantages and possible limitations of the use of echocardiography in the highly contagious disease pandemic is provided.
About the Authors
M. N. Alekhin
Central State Medical Academy of the Administrative Department of the President of the Russian Federation; Central Clinical Hospital of the Presidential Administration of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
S. I. Ivanov
Central State Medical Academy of the Administrative Department of the President of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
A. I. Stepanova
Central State Medical Academy of the Administrative Department of the President of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic disease on COVID‑19 in China. Clin Res Cardiol. 2020:109(5):531–538. doi: 10.1007/s00392–020–01626–9.
2. Skulstad H., Cosyns B., Popescu B. A., et al. COVID‑19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020;21(6):592–598. doi: 10.1093/ehjci/jeaa072.
3. Kirkpatrick J. N., Mitchell C., Taub C., Kort S., Hung J., Swaminathan M. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology. J Am Soc Echocardiogr. 2020;33(6):648–653. doi: 10.1016/j.echo.2020.04.001.
4. Wahi S., Thomas L., Stanton T, et al. CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID‑19 Pandemic. Heart Lung Circ. 2020;29(6):e78–e83. doi: 10.1016/j.hlc.2020.04.003.
5. Sattarzadeh Badkoubeh R., Almassi N., Moshkani Farahani M., et al. The Iranian Society of Echocardiography (ISE) Statement on Performing Echocardiography During the COVID‑19 Pandemic. Curr Probl Cardiol. 2020;45(8):100620. doi: 10.1016/j.cpcardiol.2020.100620.
6. Hu H., Ma F., Wei X., Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020; ehaa190. doi: 10.1093/eurheartj/ehaa190.
7. Bangalore S., Sharma M. H. A., Slotwiner A., Yatskar L., Harari R., Shah B., Ibrahim H., Friedman G. H., Thompson C., Alviar C. L., Chadow H. L., Fishman G. I., Reynolds H.R., Keller N., Hochman J. S. ST‑Segment Elevation in Patients with Covid‑19 — A Case Series. N Engl J Med. 2020;382(25):2478–2480. doi: 10.1056/NEJMc2009020.
8. Meyer P., Degrauwe S., Delden C. V., Ghadri J. R., Templin C. Typical takotsubo syndrome triggered by SARS‑CoV‑2 infection. Eur Heart J. 2020;41(19):1860. doi: 10.1093/eurheartj/ehaa306.
9. Dweck M. R., Bularga A., Hahn R.T, Bing R., Lee K. K., Chapman A. R., White A., Salvo G. D., Sade L. E., Pearce K., Newby D. E., Popescu B. A., Donal E., Cosyns B., Edvardsen T., Mills N. L., Haugaa K. Global evaluation of echocardiography in patients with COVID‑19. Eur Heart J Cardiovasc Imaging. 2020; jeaa178. doi: 10.1093/ehjci/jeaa178.
10. Churchill T. W., Bertrand P. B., Bernard S., Namasivayam M., Churchill J., Crousillat D., Davis E. F., Hung J., Picard M. H. Echocardiographic Features of COVID‑19 Illness and Association with Cardiac Biomarkers. J Am Soc Echocardiogr. 2020; S0894–7317 (20) 30335–7. doi: 10.1016/j.echo.2020.05.028.
11. Rath D., Petersen ‑ Uribe Á., Avdiu A., Witzel K., Jaeger P., Zdanyte M., Heinzmann D., Tavlaki E., Müller K., Gawaz M. P. Impaired cardiac function is associated with mortality in patients with acute COVID‑19 infection. Clin Res Cardiol. 2020;1–9. doi: 10.1007/s00392–020–01683–0.
12. Mahmoud ‑ Elsayed H. M., Moody W. E., Bradlow W. M., Khan ‑ Kheil A. M., Senior J., Hudsmith L. E., Steeds R. P. Echocardiographic Findings in Patients With COVID‑19 Pneumonia. Can J Cardiol. 2020; S0828–282X(20)30509–2. doi: 10.1016/j.cjca.2020.05.030.
13. Li Y., Li H., Zhu S., Xie Y., Wang B., He L., Zhang D., Zhang Y., Yuan H., Wu C., Sun W., Zhang Y., Li M., Cui L., Cai Y., Wang J., Yang Y., Lv Q., Zhang L., Xie M. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID‑19. JACC Cardiovasc Imaging. 2020; S1936–878X(20)30342–9. doi: 10.1016/j.jcmg.2020.04.014.
14. Kogan E. A., Berezovskiy Yu.S., Blagova O. V., Kukleva A. D., Bogacheva G. A., Kurilina E. V., Kalinin D. V., Bagdasaryan T. R., Semyonova L. A., Gretsov E. M., Ergeshov A. E., Fomin V. V. Miocarditis in Patients with COVID‑19 Confirmed by Immunohistochemical. Kardiologiia. 2020;60(7):4–10. In Russian
15. Stefanini G. G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M., Metra M., Curello S., Maffeo D., Pero G., Cacucci M., Assanelli E., Bellini B., Russo F., Ielasi A., Tespili M., Danzi G. B., Vandoni P., Bollati M., Barbieri L., Oreglia J., Lettieri C., Cremonesi A., Carugo S., Reimers B., Condorelli G., Chieffo A. ST‑Elevation Myocardial Infarction in Patients With COVID‑19: Clinical and Angiographic Outcomes. Circulation. 2020;141(25):2113–2116. doi: 10.1161/CIRCULATIONAHA.120.047525.
16. Irabien‑Ortiz Á., Carreras‑Mora J., Sionis A., Pàmies J., Montiel J., Tauron M. Fulminant myocarditis due to COVID‑19. Rev Esp Cardiol (Engl Ed). 2020;73(6):503–504. doi: 10.1016/j.rec.2020.04.005.
17. Zeng J. H., Liu Y. X., Yuan J., Wang F. X., Wu W. B., Li J. X., Wang L. F., Gao H., Wang Y., Dong C. F., Li Y. J., Xie X. J., Feng C., Liu L. First case of COVID‑19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;1–5. doi: 10.1007/s15010‑020‑01424‑5.
18. Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W., Cheng Y., Yan J., Ping H., Zhou Q. Suspected myocardial injury in patients with COVID‑19: Evidence from front‑line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116–121 doi: 10.1016/j.ijcard.2020.03.087.
19. Ward R. P., Lee L., Ward T. J., Lang R. M. Utilization and Appropriateness of Transthoracic Echocardiography in Response to the COVID‑19 Pandemic. JAm Soc Echocardiogr. 2020;33(6):690–691. doi: 10.1016/j.echo.2020.04.006.
Review
For citations:
Alekhin M.N., Ivanov S.I., Stepanova A.I. Clinical value of echocardiography in patients with COVID-19: a systematic review. Modern Functional Diagnostics (4). 2020;(32):8-13. (In Russ.) https://doi.org/10.33667/2078-5631-2020-32-8-13
Views:
455
Email this article 